<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04898335</url>
  </required_header>
  <id_info>
    <org_study_id>21-0110</org_study_id>
    <nct_id>NCT04898335</nct_id>
  </id_info>
  <brief_title>Tendyne European Experience Registry</brief_title>
  <acronym>TENDER</acronym>
  <official_title>TENDyne European expeRience Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LMU Klinikum</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LMU Klinikum</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      TENDER is a multicenter, single-device, retrospective and prospective, observational study to&#xD;
      assess safety and efficacy of the Tendyne Mitral Valve System in a real-world population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mitral regurgitation (MR) is a common disease and is associated with high morbidity and&#xD;
      mortality if left untreated. Due to age and comorbidities, patients are often ineligible for&#xD;
      surgical repair or replacement. Over the last years, transcatheter systems have been&#xD;
      introduced as an alternative therapeutic approach. The Tendyne Mitral Valve System (Abbott&#xD;
      Vascular, Roseville, Minnesota) is a transcatheter transapical, self-expanding valve&#xD;
      prosthesis for mitral valve replacement. A recent study has proven safety and feasibilty of&#xD;
      the system, leading to commercial approvement (CE mark). However, data on real world&#xD;
      experience with the system are not available.&#xD;
&#xD;
      TENDER is a multicenter, single-device, retrospective and prospective, observational study.&#xD;
      Objectives of the study are 1) to assess early outcomes, including safety and efficacy, in&#xD;
      patients treated with the Tendyne Mitral Valve System for severe MR at 30 days, 2) to assess&#xD;
      clinical outcomes in patients treated with the Tendyne Mitral Valve System for severe MR at 1&#xD;
      year and 3 year follow-up, and 3) to identify echocardiographic and CT-based anatomic&#xD;
      predictors associated with outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2027</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Rate of procedural success</measure>
    <time_frame>30 days</time_frame>
    <description>Device success (structural and functional); absence of death, stroke, life-threatening bleeding, major vascular or cardiac structural complications, acute kidney injury, myocardial infarction, heart failure and valve-related dysfunction requiring repeat procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of peri-procedural myocardial infarction</measure>
    <time_frame>1 day</time_frame>
    <description>Myocardial infarction during the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of conversion to open-heart surgery</measure>
    <time_frame>1 day</time_frame>
    <description>Conversion to open-heart surgery during the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of cardiac tamponade</measure>
    <time_frame>1 day</time_frame>
    <description>Cardiac Tamponade during the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of procedural mortality</measure>
    <time_frame>1 day</time_frame>
    <description>Death during the index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of technical success (cumulative endpoint according to MVARC)</measure>
    <time_frame>1 day</time_frame>
    <description>Absence of procedural mortality, successful access, delivery and retrieval of the delivery system, successful deployment and positioning, freedom from emergency surgery) Device success (according to MVARC): absence of procedural mortality or stroke, proper placement and positioning, freedom from unplaned procedure related to the device or access, continued safety and performance of the device (no structural or functional failure, no technical complications, reduction of MR ≤ 2+ and mitral valve gradient &lt; 5 mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device success (cumulative endpoint according to MVARC)</measure>
    <time_frame>30 days, 1 year and 3 years</time_frame>
    <description>Absence of procedural mortality or stroke, proper placement and positioning, freedom from unplaned procedure related to the device or access, continued safety and performance of the device (no structural or functional failure, no technical complications, reduction of MR ≤ 2+ and mitral valve gradient &lt; 5 mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New York Heart Association (NYHA) functional class</measure>
    <time_frame>30 days, 1 year and 3 years</time_frame>
    <description>class I - IV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-minute walk distance (6MWD)</measure>
    <time_frame>30 days, 1 year and 3 years</time_frame>
    <description>in m</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BNP/NT-proBNP level</measure>
    <time_frame>30 days, 1 year and 3 years</time_frame>
    <description>in pg/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral regurgitation severity grade</measure>
    <time_frame>30 days, 1 year and 3 years</time_frame>
    <description>grade 0/1+/2+/3+/4+</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left and right ventricular dimensions</measure>
    <time_frame>30 days, 1 year and 3 years</time_frame>
    <description>left/right ventricular end-diastolic/-systolic diameter (in mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular function</measure>
    <time_frame>30 days, 1 year and 3 years</time_frame>
    <description>LVEF in percent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular function</measure>
    <time_frame>30 days, 1 year and 3 years</time_frame>
    <description>TAPSE in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary artery pressure</measure>
    <time_frame>30 days, 1 year and 3 years</time_frame>
    <description>in mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tricuspid regurgitation severity grade</measure>
    <time_frame>30 days, 1 year and 3 years</time_frame>
    <description>grade 1-5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transprosthetic gradient</measure>
    <time_frame>30 days, 1 year and 3 years</time_frame>
    <description>in mmHg</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Mitral Regurgitation</condition>
  <arm_group>
    <arm_group_label>Tendyne</arm_group_label>
    <description>all patients treated with a Tendyne Mitral Valve System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tendyne Mitral Valve System</intervention_name>
    <description>Tendyne Mitral Valve System for mitral valve disease in a commercial setting</description>
    <arm_group_label>Tendyne</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients undergoing Implantation of Tendyne Mitral Valve System at the&#xD;
        participating centres.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients treated with the Tendyne Mitral Valve System for mitral valve disease in a&#xD;
             commercial setting&#xD;
&#xD;
          -  Patients providing written informed consent in compliance with the protocol, the&#xD;
             ICH-GCP and all national legal and regulatory requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients not providing written informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Joerg Hausleiter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>LMU Klinikum Munich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joerg Hausleiter, MD</last_name>
    <phone>0049894400</phone>
    <phone_ext>72360</phone_ext>
    <email>joerg.hausleiter@med.uni-muenchen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mirjam Wild, MD</last_name>
    <email>mirjam.wild@insel.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitaetsklinikum Linz</name>
      <address>
        <city>Linz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Zierer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Wien</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Andreas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Dubois</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Modine</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Augustin Coisine</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe Leclercq</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Dumonteil</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW</name>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanja Rudolph</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Unbehaun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Sedaghat</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Walther</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UKE Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leonard Conradi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Koeln</name>
      <address>
        <city>Koeln</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Baldus</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herzentrum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philipp Lurz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan von Bardeleben</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>DHZ München</name>
      <address>
        <city>Münich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hendrik Ruge</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Regensburg</name>
      <address>
        <city>Regensburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bernhard Unsoeld</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Robert-Bosch-Krankenhaus Stuttgart</name>
      <address>
        <city>Stuttgart</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philipp Nikolai</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Geisler</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ICH - Istituto Clinico Humanitas</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Fumero</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Pisa</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Sonia Petronio</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University hospital Oslo</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gry Dahle</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Puerto de Hierro Madrid</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa Monivas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University hospital Madrid</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Nombela</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Valladolid</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ignacio Amat-Santos</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Vigo</name>
      <address>
        <city>Vigo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodrigo Estevez-Loureiro</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Karolinska University Stockholm</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andreas Rueck</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsspital Basel</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oliver Reuthebuch</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Inselspital Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabien Praz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Brompton London</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alison Duncan</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Norway</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 30, 2021</study_first_submitted>
  <study_first_submitted_qc>May 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2021</study_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>LMU Klinikum</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Jörg Hausleiter</investigator_full_name>
    <investigator_title>Prof. Dr. med. Jörg Hausleiter</investigator_title>
  </responsible_party>
  <keyword>mitral regurgitation</keyword>
  <keyword>Tendyne</keyword>
  <keyword>transcatheter mitral valve replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

